🎯 check Bardoxolone Methyl (RTA 402) product page
Bardoxolone Methyl (RTA 402) is a potent, covalent KEAP1 inhibitor and NRF2 activator. It affects NRF2 and NF-κB signaling pathways by forming an adduct with KEAP1 and blocking IκB kinase, inhibiting inflammation, oxidative stress, and apoptosis while promoting cytoprotection.